The most notable takeaway from the first-ever “Quad” leaders meeting involving the US, India, Japan and Australia at the weekend was the agreement on expanding the global vaccine supply. The vaccination capacity of India will be increased to produce 1 billion doses by 2022, the leaders announced in a joint statement, as US and Japan plan to fund Indian production of Johnson and Johnson’s single-dose vaccine, which Australia will then distribute across Southeast Asia.
This will undoubtedly boost India’s vaccine diplomacy efforts where it has been providing vaccines to the developing countries, both in its neighbourhood as well as globally. So far 71 countries have received vaccines manufactured in India, fast garnering it the title of “the world’s pharmacy”. Largely, these are developing countries which did not have adequate access to the vaccine.
Please click here to read the full “The Quad gives a boost to India’s vaccine diplomacy” article published at The Interpreter, written by Griffith Asia Institute PhD Candidate, Teesta Prakash.